Abstract
FIGS, Inc. is scheduled to report first‑quarter 2026 results on May 7, 2026 Post Market; investors are watching revenue momentum, margin durability, and operating leverage following a strong fourth quarter and a constructive start to 2026.
Market Forecast
Based on current projections, FIGS, Inc. is expected to deliver first‑quarter revenue of 152.65 million US dollars, implying 28.09% year‑over‑year growth; the current quarter EPS estimate is 0.01 US dollars, which reflects a 1,489% year‑over‑year increase from a small base, while EBIT is projected at 1.76 million US dollars, up 219.36% year‑over‑year. There is no explicit outlook for gross margin or net margin in the available estimates, but consensus implies positive operating leverage against last year’s Q1 comparison.
The core product engine remains the key near‑term driver, with management’s recent update indicating healthy demand through the digital channel and expanded replenishment cadence across core offerings. The most promising opportunity remains the non‑medical workwear and lifestyle adjacency, a growing contributor with a last‑quarter revenue base of 39.09 million US dollars; company‑level growth was 32.97% year‑over‑year in Q4, and revenue is projected to grow 28.09% year‑over‑year in Q1, framing the trajectory for expansion initiatives.
Last Quarter Review
In the previous quarter, FIGS, Inc. reported revenue of 201.90 million US dollars, a gross profit margin of 62.94%, GAAP net profit attributable to the company of 18.51 million US dollars with a net profit margin of 9.17%, and adjusted EPS of 0.10 US dollars; revenue rose 32.97% year‑over‑year and adjusted EPS increased 900% year‑over‑year.
A key financial highlight was sharp operating improvement: EBIT reached 18.81 million US dollars, up 111.33% year‑over‑year, reflecting solid incremental margins on higher volume. By business mix, core medical scrubs generated approximately 162.80 million US dollars and non‑medical workwear contributed about 39.09 million US dollars; the company delivered 32.97% year‑over‑year growth at the consolidated level in Q4, while segment‑level growth rates were not disclosed.
Current Quarter Outlook
Core product engine and near‑term revenue cadence
FIGS, Inc.’s first‑quarter revenue is projected at 152.65 million US dollars, a 28.09% year‑over‑year increase off last year’s reset base. This cadence embeds normalization from the holiday‑enhanced Q4 while retaining momentum across replenishment cycles and new colorways that have historically supported repeat purchase frequency. Against a lower sequential revenue base than the fourth quarter, the year‑over‑year growth profile indicates sustained demand elasticity within the core catalog and continued customer engagement through direct channels.
The trajectory of operating leverage is a second focal point. The current quarter EPS estimate is 0.01 US dollars, implying 1,489% year‑over‑year growth from last year’s modest Q1 per‑share result; EBIT is projected at 1.76 million US dollars, up 219.36% year‑over‑year. These forecast deltas suggest that fixed‑cost absorption and fulfillment efficiency may contribute disproportionately to incremental profitability as volume scales, although the absolute earnings base remains light in a seasonally softer first quarter.
Pricing discipline and promotional mix bear monitoring. Last quarter’s 62.94% gross margin provides a constructive reference point for product‑level economics, but the lack of a formal margin forecast necessitates attention to marketing intensity, new product introductions, and logistics costs. If marketing spend is front‑loaded to seed new cohorts or support broadened offerings, unit economics could remain healthy while operating margin progression skews more to the second half; if spend is moderated, EBIT variance could favor the current quarter even at a lower seasonal revenue base.
Most promising growth vector: non‑medical workwear and lifestyle adjacency
Non‑medical workwear and lifestyle adjacency represents the clearest expansion runway from the existing customer base, supported by brand affinity and cross‑sell opportunities. In last quarter’s mix, this category contributed approximately 39.09 million US dollars, establishing a material base from which incremental colorways, fabrications, and accessory introductions can widen the purchasing basket. Given the company’s consolidated growth of 32.97% year‑over‑year in Q4 and a projected 28.09% year‑over‑year increase in Q1, the backdrop for this category is favorable even as segment‑specific year‑over‑year rates are not disclosed.
Execution focus in this area centers on SKU productivity and inventory discipline. A curated pipeline of non‑scrub essentials can support frequency without diluting margin structure, particularly if replenishment assortments are synchronized with core scrub demand patterns. Additionally, targeted digital merchandising that maps to the existing professional audience may allow efficient acquisition of adjacent use cases with limited incremental marketing cost.
From a financial lens, the adjacency’s contribution to EBIT should expand as the product engine scales—provided that return rates remain controlled and average order values lift through bundling. The current quarter’s 219.36% year‑over‑year EBIT growth estimate at the consolidated level underscores the potential for operating leverage when new lines layer onto a direct channel with established fulfillment capabilities. The key sensitivity is whether promotional pull‑forwards are necessary to introduce newer categories; disciplined launch calendars and limited‑edition drops can mitigate markdown risk while supporting engagement.
Key stock drivers this quarter: revenue quality, operating leverage, and guidance tone
The first determinant for share performance will be revenue quality—specifically, the balance between new customer adds and repeat purchasing, and the degree to which demand is price‑ or promotion‑assisted. A 28.09% year‑over‑year revenue increase is constructive, but the market will parse cohort behavior and order frequency indicators to assess durability into Q2 and beyond. Maintaining healthy gross margin near last quarter’s 62.94% reference would signal that assortment and pricing strategy are holding, even as seasonal patterns normalize volume from Q4 highs.
The second driver is the translation of top‑line growth into EBIT and EPS. With Q1 EBIT estimated at 1.76 million US dollars and EPS at 0.01 US dollars, year‑over‑year comparisons appear favorable; investors will focus on whether fulfillment and marketing efficiency can support further margin expansion in subsequent quarters. Given the strong Q4 base, evidence of cost control and improving throughput in Q1 would help reinforce the multi‑quarter operating leverage story.
Finally, the guidance tone can meaningfully sway sentiment, particularly around cadence for the remainder of 2026. Clarity on the pace of product introductions, the planned marketing investment envelope, and the expected contribution from new categories will frame the sustainability of double‑digit growth. Confirmation that the consolidated revenue growth algorithm remains intact—alongside stable unit economics—would likely be received positively, while any indications of heightened promotional intensity or logistics headwinds could temper enthusiasm.
Analyst Opinions
Market views skew bullish during the first four months of 2026, with a majority of published opinions constructive on the near‑term trajectory. Among the most recent updates, several well‑known institutions and analysts indicated either upgrades or positive outlooks following the strong fourth‑quarter print and early‑year trading strength, outweighing cautious stances in the period reviewed.
KeyBanc upgraded FIGS to Overweight with a 17.00 US dollars price target, citing a reset in expectations and improving revenue acceleration that strengthened through year‑end; shares rallied on the callout, highlighting increased investor confidence in execution. BTIG’s Robert Drbul maintained a Buy rating and set a 20.00 US dollars price target, reflecting conviction that the product engine and direct channel monetization can continue to support healthy growth and operating leverage in 2026. Oppenheimer characterized the recovery as sustained and improving, noting operational discipline and easing macro and sector headwinds; the firm expects first‑quarter adjusted EBITDA of 10.80 million US dollars and sales growth of about 22%, a framing consistent with consensus revenue estimates and the broader expectation of margin traction as the year progresses.
The majority view emphasizes three core pillars. First, revenue momentum appears better aligned with balanced assortment and replenishment, suggesting that recent outperformance can translate into steadier quarterly execution rather than a single‑quarter anomaly. Second, unit economics remain attractive, with last quarter’s 62.94% gross margin establishing a constructive baseline and consensus pointing to pronounced year‑over‑year operating improvement in Q1 (EBIT up 219.36% and EPS up 1,489% from a small base). Third, as the non‑medical workwear and lifestyle adjacency scales from a 39.09 million US dollars contribution last quarter, analysts see incremental cross‑sell and frequency gains that can add to top‑line durability while preserving gross margin integrity.
In synthesizing the bullish camp’s arguments, the expected 28.09% year‑over‑year revenue increase in Q1 acts as a near‑term validation milestone. If the company pairs that growth with leaner fulfillment costs and stable promotional intensity, the operating leverage embedded in the model should continue to surface through 2026. Analysts supportive of the name also point to the combination of a robust direct channel, disciplined assortment management, and a growing adjacency as catalysts that can compound earnings power beyond the seasonal first‑quarter trough.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments